Nxera Pharma Co., Ltd.

Nxera Pharma Co., Ltd.verified

SOLTF

Price:

$5

Market Cap:

$75.83B

Nxera Pharma Co., Ltd. develops and sells biopharmaceutical products in Japan, Switzerland, the United States, Bermuda, and the United Kingdom. Its product portfolio products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair and Breezhaler for the treatment of asthma; ORAVI, a novel formulation for the treatment of oropharyngeal candidiasis; and PIVLAZ for the treatment of cerebral vasospasm indications. The company's development products pipeline consists of HTL0039732 for immuno-oncology indications; HTL0048149 for schizophrenia disorders; Daridorexant for the treatment of insomnia; HTL0016878 for schizophrenia and other n...[Read more]

Industry

Biotechnology

IPO Date

2013-09-04

Stock Exchange

OTC

Ticker

SOLTF

The Enterprise Value as of December 2025 (TTM) for Nxera Pharma Co., Ltd. (SOLTF) is 107.56B

According to Nxera Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 107.56B. This represents a change of -11.69% compared to the average of 121.79B of the last 4 quarters.

Nxera Pharma Co., Ltd. (SOLTF) Historical Enterprise Value (quarterly & annually)

How has SOLTF Enterprise Value performed in the past?

The mean historical Enterprise Value of Nxera Pharma Co., Ltd. over the last ten years is 141.45B. The current 107.56B Enterprise Value has changed 7.50% with respect to the historical average. Over the past ten years (40 quarters), SOLTF's Enterprise Value was at its highest in in the June 2016 quarter at 306.48B. The Enterprise Value was at its lowest in in the December 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

141.45B

Median

137.40B

Minimum

49.09B

Maximum

247.07B

Nxera Pharma Co., Ltd. (SOLTF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nxera Pharma Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 341.77%

Maximum Annual Enterprise Value = 247.07B

Minimum Annual Increase = -64.10%

Minimum Annual Enterprise Value = 49.09B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024129.66B-8.79%
2023142.16B2.99%
2022138.03B11.53%
2021123.76B4.58%
2020118.34B-22.58%
2019152.85B211.36%
201849.09B-64.10%
2018136.76B-22.65%
2017176.80B-28.44%
2016247.07B341.77%

Nxera Pharma Co., Ltd. (SOLTF) Average Enterprise Value

How has SOLTF Enterprise Value performed in the past?

The current Enterprise Value of Nxera Pharma Co., Ltd. (SOLTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

136.62B

5-year avg

130.39B

10-year avg

141.45B

Nxera Pharma Co., Ltd. (SOLTF) Enterprise Value vs. Peers

How is SOLTF’s Enterprise Value compared to its peers?

Nxera Pharma Co., Ltd.’s Enterprise Value is greater than GenSight Biologics S.A. (36.30M), greater than Basilea Pharmaceutica AG (601.54M), greater than Viva Biotech Holdings (4.12B), greater than MedinCell S.A. (859.57M), greater than 4DMedical Limited (977.93M), greater than BioInvent International AB (publ) (1.43B), greater than Race Oncology Limited (482.80M), greater than Avacta Group Plc (355.89M), greater than ManifestSeven Holdings Corporation (22.25M), less than JCR Pharmaceuticals Co., Ltd. (114.39B),

Build a custom stock screener for Nxera Pharma Co., Ltd. (SOLTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nxera Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nxera Pharma Co., Ltd. (SOLTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nxera Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Nxera Pharma Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Nxera Pharma Co., Ltd. (SOLTF)?

What is the 3-year average Enterprise Value for Nxera Pharma Co., Ltd. (SOLTF)?

What is the 5-year average Enterprise Value for Nxera Pharma Co., Ltd. (SOLTF)?

How does the current Enterprise Value for Nxera Pharma Co., Ltd. (SOLTF) compare to its historical average?